The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents
Clinical trial NCT00899678 · TERMINATED
Trial details
- NCT number
- NCT00899678
- Sponsor
- UCB Celltech
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2012-07-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.